Management of adult vitiligo: approved topical JAK inhibitor and standard therapies
Systemic regimens show benefits in selected clinical scenarios, although supporting evidence remains heterogeneous. Treatment selection should be individualized based on disease activity, extent, anatomical site, and patient preferences.
Authors
- Francesca Paola Sasso
- Antonio Di Guardo (ORCID: https://orcid.org/0000-0002-0117-346X)
- Maria Elisabetta Greco (ORCID: https://orcid.org/0009-0008-5067-8190)
- Concetta Potenza (ORCID: https://orcid.org/0000-0002-6300-8697)
- Ilaria Proietti (ORCID: https://orcid.org/0000-0003-3795-3190)
- A. Di
- Steven Paul Nisticò (ORCID: https://orcid.org/0000-0002-3828-0883)
- Luigi Angelo Fiorito
- Nicola Perrotta (ORCID: https://orcid.org/0000-0002-9571-2670)
- Francesca Feresin
- Giovanni Pellacani
- Carmen Cantisani
Institutions
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2026-02-16
- DOI
- https://doi.org/10.1080/09546634.2026.2627721
- Primary Topic
- melanin and skin pigmentation
- Type
- article
- Field-Weighted Citation Impact
- 0.00